Sona Asset Management »

Biomarin Pharma Inc convertible/ shares owned by Sona Asset Management

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Sona Asset Management from 13F filings

Historical chart of Sona Asset Management investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by Sona Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Sona Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $23B 23M 970.89

More positions owned by Sona Asset Management

Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Apollo Global Mgmt Ser A Mand Cnv (APO.PA)
Insight Enterprises Note 0.750% 2/1
Ncl Corp Note 2.500% 2/1
Rapid7 Note 0.250% 3/1
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Greenfire Res Com Shs (GFR)
Neurocrine Biosciences Note 2.250% 5/1
Dropbox Note3/0
Biomarin Pharmaceutical Note 0.599% 8/0
Dropbox Note3/0
Sea Note 2.375%12/0
Mongodb Note 0.250% 1/1
Sea Note 0.250% 9/1
American Airlines Group Note 6.500% 7/0

View all positions for Sona Asset Management

Top funds holding Biomarin Pharma Inc convertible/

OZ Management
Millennium Management
Citigroup
Aviva
Two Sigma Investments
Calamos Advisors
Partner Fund Management
Bank of America Corporation
Lord, Abbett & Co
Sunrise Partners Limited Partnership
Centiva Capital
Jpmorgan Chase & Co
RWC Asset Management
MacKay Shields
Palisade Capital Management

View all funds holding Biomarin Pharma Inc convertible/